Hypergastrinaemia: Clinical Trials

4 trials for Hypergastrinaemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow Hypergastrinaemia: new trials by email Literature Review of Hypergastrinaemia trials Research Report on Hypergastrinaemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
YF476 and Type I Gastric Carcinoids
YF476 - Chronic Atrophic Gastritis, Hypergastrinaemia
Phase 2CompletedTrio Medicines Ltd.82011-01-042019-08-19
Effects of YF476 and Rabeprazole on Gastric Function
YF476, Rabeprazole - Hypergastrinaemia
Phase 1CompletedTrio Medicines Ltd.322006-08-012012-10-03
Effect of Repeated Doses of YF476 on Stomach Acidity
YF476, Placebo - Hypergastrinaemia
Phase 1CompletedTrio Medicines Ltd.102001-10-012012-05-18
Effect of Single Doses of YF476 on Stomach Acidity
YF476, Placebo - Hypergastrinaemia
Phase 1CompletedTrio Medicines Ltd.122001-10-012012-05-18

Narrower conditions

Gastritis, Atrophic (1)

Broader conditions

Digestive System Diseases (1)  ·  Gastritis (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Stomach Diseases (1)

Interventions

YF 476 (4)  ·  Rabeprazole (1)

Sponsors

Trio Medicines Ltd. (4)

Countries

United Kingdom (4)

Top investigators

Malcolm Boyce (3)  ·  Malcolm Boyce, BSc FRCP FFPM (1)  ·  Mark Pritchard, PhD FRCP (1)

Results publications

PMID 24098507